Salehi, Mohammadreza, et al. “Relapse of COVID-19-Associated Mucormycosis in Patients Receiving Posaconazole As Maintenance Treatment”. The Journal of Infection in Developing Countries, vol. 18, no. 09.1, Sept. 2024, pp. S163-S169, doi:10.3855/jidc.19645.